Col1A1 Production and Apoptotic Resistance in TGF-β1-Induced Epithelial-to-Mesenchymal Transition-Like Phenotype of 603B Cells

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Liu, Jun ^a   Eischeid, Alex N ^a   Chen, Xian Ming ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; MICRORNA 29; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SNAIL1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL STRUCTURE; CELL SURVIVAL; CHOLANGIOCYTE; COL1A1 GENE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; IN VITRO STUDY; LIVER CELL; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN INDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BILE DUCTS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; COLLAGEN TYPE I; DNA PRIMERS; EPITHELIAL-MESENCHYMAL TRANSITION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE KNOCKDOWN TECHNIQUES; LUCIFERASES; MICE; MICRORNAS; PHENOTYPE; PROPIDIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84870862301     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051371     Document Type: Article

References (38)

1. Bataller R, Brenner DA, (2005) Liver fibrosis. J Clin Invest 115: 209-218.
2. Friedman SL, (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology. 134: 1655-1669.
3. Beaussier M, Wendum D, Schiffer E, Dumont S, Rey C, et al. (2007) Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries. Lab Invest 87: 292-303.
4. Wells RG, (2008) Cellular sources of extracellular matrix in hepatic fibrosis. Clin Liver Dis 12: 759-768.
5. Priester S, Wise C, Glaser SS, (2010) Involvement of cholangiocyte proliferation in biliary fibrosis. World J Gastrointest Pathophysiol 1: 30-37.
6. Glaser SS, Gaudio E, Miller T, Alvaro D, Alpini G (2009) Cholangiocyte proliferation and liver fibrosis. Expert Rev Mol Med 11: e7. Available: http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=4187152. Accessed 2009 Apr 30.
7. Omenetti A, Porrello A, Jung Y, Yang L, Popov Y, et al. (2008) Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest 118: 3331-3342.
8. Rygiel KA, Robertson H, Marshall HL, Pekalski M, Zhao L, et al. (2008) Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab Invest 88: 112-123.
9. Sato Y, Harada K, Ozaki S, Furubo S, Kizawa K, et al. (2007) Cholangiocytes with mesenchymal features contribute to progressive hepatic fibrosis of the polycystic kidney rat. Am J Pathol 171: 1859-1871.
10. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 39: 871-890.
11. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA, (2009) Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119: 1438-1449.
12. Kalluri R, Weinberg RA, (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
13. Jung Y, Brown KD, Witek RP, Omenetti A, Yang L, et al. (2008) Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. Gastroenterology 134: 1532-1543.
14. Omenetti A, Yang L, Li YX, McCall SJ, Jung Y, et al. (2007) Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation. Lab Invest 87: 499-514.
15. Xu J, Lamouille S, Derynck R, (2009) TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19: 156-172.
16. Inagaki Y, Okazaki I, (2007) Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut 56: 284-292.
17. Kaimori A, Potter J, Kaimori JY, Wang C, Mezey E, et al. (2007) Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem 282: 22089-22101.
18. Xia JL, Dai C, Michalopoulos GK, Liu Y, (2006) Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol 168: 1500-1512.
19. Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, et al. (2007) Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282: 23337-23347.
20. Zeisberg M, Neilson EG, (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119: 1429-1437.
21. Gregory PA, Bracken CP, Bert AG, Goodall GJ, (2008) MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 7: 3112-3118.
22. Maurer B, Stanczyk J, Jüngel A, Akhmetshina A, Trenkmann M, et al. (2010) MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 62: 1733-1743.
23. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, et al. (2011) Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53: 209-218.
24. Van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, et al. (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 105: 13027-13032.
25. Song J, (2007) EMT or apoptosis: a decision for TGF-beta. Cell Res 17: 289-290.
26. Valdés F, Murillo MM, Valverde AM, Herrera B, Sánchez A, et al. (2004) Transforming growth factor-beta activates both pro-apoptotic and survival signals in fetal rat hepatocytes. Exp Cell Res 292: 209-18.
27. Franco DL, Mainez J, Vega S, Sancho P, Murillo MM, et al. (2010) Snail1 suppresses TGF-beta-induced apoptosis and is sufficient to trigger EMT in hepatocytes. J Cell Sci 123: 3467-3477.
28. Hanada S, Harada M, Koga H, Kawaguchi T, Taniguchi E, et al. (2003) Tumor necrosis factor-alpha and interferon- gamma directly impair epithelial barrier function in cultured mouse cholangiocytes. Liver Int 23: 3-11.
29. Decker P, Isenberg D, Muller S, (2000) Inhibition of caspase-3-mediated poly(ADP-ribose) polymerase (PARP) apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis. J Biol Chem 275: 9043-9046.
30. Clotman F, Jacquemin P, Plumb-Rudewiez N, Pierreux CE, Van der Smissen P, et al. (2005) Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors. Genes Dev 19: 1849-1854.
31. Escrivà M, Peiró S, Herranz N, Villagrasa P, Dave N, et al. (2008) Repression of PTEN phosphatase by Snail1 transcriptional factor during gamma radiation-induced apoptosis. Mol Cell Biol 28: 1528-1540.
32. Kajita M, McClinic KN, Wade PA, (2004) Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Mol Cell Biol 24: 7559-7566.
33. Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, et al. (2009) Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 27: 2059-2068.
34. Popov Y, Schuppan D, (2010) Epithelial-to-mesenchymal transition in liver fibrosis: dead or alive? Gastroenterology 139: 722-725.
35. Scholten D, Osterreicher CH, Scholten A, Iwaisako K, Gu G, et al. (2010) Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology 139: 987-998.
36. Taura K, Miura K, Iwaisako K, Osterreicher CH, Kodama Y, et al. (2010) Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 51: 1027-1036.
37. Chu AS, Diaz R, Hui JJ, Yanger K, Zong Y, et al. (2011) Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology 53: 1685-1695.
38. Patsenker E, Popov Y, Stickel F, Jonczyk A, Goodman SL, et al. (2008) Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. Gastroenterology 135: 660-670.